Dr Reddy's Q1 Result: PAT rises 18% to Rs 1,405 crore
Dr Reddy's Laboratories on Wednesday reported an 18 per cent increase in consolidated profit after tax at Rs 1,405 crore in the June quarter, fuelled by US generics and strong performance in Russia.
The consolidated total revenue from operations was at Rs 6,757.9 crore, compared to Rs 5,232.9 crore in the year-ago period. Image Courtesy: Reuters.